Article
Analysis for loss of heterozygosity on chromosome arm 13q by STR analysis or SNP sequencing can replace analysis of FLT3-ITD to detect patients with prognostically adverse AML.
Genes, chromosomes & cancer - 1 Dec 2014
Schnittger Susanne, Haferlach Claudia, Kern Wolfgang, Haferlach Torsten
Abstract excerpt
We aimed at developing novel assays for Loss of Heterozygosity (LOH) detection on 13q as a substitute for FLT3-ITD analysis to identify acute myeloid leukemia (AML) patients with high risk of shorter survival. To this aim, we first analyzed a selected cohort of 185 patients with (n = 138) or with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
